2. Gene therapy for haemophilia a long and winding road 12. recent progress in anticoagulant therapy oral direct inhibitors of thrombin and factor Xa 20 Molecular mechanism of inside out integri…
893. Efficiacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage a meta analysis of controlled studies 899. Genetic determinants o…
1097. Platelets and the innate immune system mechanisms of bacterial induced platelet activation 1108. Economic impact of an electronic alert system to prevent venous thromboembolism in hospitali…
1292. Thrombin inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis 1301. Impact of vascullar disease in predictin…
663. Structure function relationship in thrombin activatable fibrinolysis inhibitor 645. Platelet immunoreceptor tyrosine based activation motif (ITAM) and hemITAM signaling and vascular integrit…
865 Coagulopathy and its management in patients with severe 875 Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedur…
421. Biosimilars of low molecular weight heparin products fostering competition or reducing biodiversity 427 contact system revisited an interface between inflamation coagulation and innate immun…
231. Shock, acute disseminated intravascular coagulation and microvascular thrombosis is shock liver the unrecognized provocateur of ischemic limb necrosis 236. Structural and functional insights …
3. International society on thrombosis and haemotosis core curiculum project core competencies in clinical thrombosis and hemostasis 28. The contact activation and kalikrein/kinin systems pathophy…
2152. Revisiting the tale of venous thromboembolism in hospitalized medical patients 2155. Central venous catheters and upper extremity deep vein thrombosis (MITH) study 2161. Bemiparin for thro…